Investment Offering

Physicians, clinics and hospitals will use the EntelMed IQ technology to remotely monitor patients using biosensors, electronic monitoring devices, electronic information and telecommunication technology to support long distance patient and clinical contact, care, advice, reminders, education, intervention, patient monitoring, and remote admissions.

Founded in 2020, EntelMed is poised to become a leading national provider of comprehensive technology-enabled healthcare through the merger and acquisition of multiple artificial intelligence (“AI”), automation, data science, and Software-as-a-Service (“SaaS”) companies valued at between $50 million to $200 million.

View By:

EntelMed
Investment Type Fund
Total Raise $2,500,000
Min. Invest $20,000
Target Hold 36 mos.
Distributions At Exit